International Journal of Radiation Oncology Biology Physics

Papers
(The H4-Index of International Journal of Radiation Oncology Biology Physics is 46. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
The R's of Radiation Therapy: Do We Need More or Do We Move On?191
If Medicine were my Spouse141
In Regard to Langé et al125
Mind Over Matter: Complete Craniospinal Irradiation or Just Treat the Spine115
Beyond Randomized Controlled Trials: Embracing Pragmatism for Evidence-Based Online Adaptive Radiation Therapy105
Small Molecule Inhibitors Targeting Transgelin-2-Actin Interaction for Therapeutic Intervention in Glioblastoma99
A First Look at Equity, Diversity, and Inclusion of Canadian Medical Physicists: Results From the 2021 COMP EDI Climate Survey94
Distance Traveled by Patients Globally to Access Radiotherapy: A Systematic Review91
Low Utilization of External Beam Radiation Therapy for Patients With Unresectable Hepatocellular Carcinoma: An Analysis of the United Network for Organ Sharing Database87
Prospective and Comprehensive Characterization of an Inpatient Radiation Oncology Consult Service: Examining Interdisciplinary Coordination of Palliative Radiation Access and Receipt86
Association of Inpatient Radiation Oncology Consult Timing with Length of Hospitalization and Opioid Utilization78
Effect of Postmastectomy Radiotherapy in Breast Cancer Patients according to Pathologic Nodal Status and Molecular Subtype after Neoadjuvant Chemotherapy76
Optimal Threshold of Smoking in Pack-Years and its Association with Survival Outcomes Among Patients Treated with Chemoradiation for Head and Neck Cancer74
Brachytherapy Capacity for Management of Cervical Cancer in Low- and Middle-Income Countries: An Updated IAEA Database Analysis73
The LMP1/Lgals1-NF-Kb-IRF1-PDL1 Axis Promotes Immune Escape in Nasopharyngeal Carcinoma71
Breast Cancer Radiotherapy Experience in a Newly Established Cancer Center in Nigeria69
Salvage Ablative Radiation Therapy for Isolated Intraabdominal Recurrences of Hepatocellular Carcinoma65
Dose-Escalated Ablative Radiotherapy as Definitive Treatment for Unresectable and Recurrent Intrahepatic Cholangiocarcinoma64
Risk of Diabetes Mellitus after Radiotherapy for Gastric Mucosa-Associated Lymphoid Tissue Lymphoma62
Trends in Private Equity Involvement in Oncology Practices in the United States62
Hypofractionated vs. Conventionally Fractionated Radiotherapy for Glioblastoma: Peripheral Blood Leukocyte Comparison prior to and Following Chemoradiation61
In Silico Trial of Computed Tomography-Guided Stereotactic Adaptive Radiotherapy (CT-STAR) for the Treatment of Abdominal Oligometastases59
Clinically Consistent Prostate Cancer Outcome Prediction Models with Machine Learning57
Perineural Invasion Combined with Pattern C of the Silva Classification System Correlates Poor Prognosis in Cervical Adenocarcinoma Following a Radical Hysterectomy56
Does hippocampal atrophy correlate with patient-reported adaptive function one year following radiotherapy? Results from a prospective trial55
Novel Enhancement of Checkpoint Inhibition Using Pulsing Radiotherapy with Concurrent and Adjuvant CPI for LAHNSCC in Elderly Patients Considered Ineligible for Curative Intent Therapy55
A National Cancer Disparities Analysis of Pacific Islanders Who Decline Radiation Therapy and Impacts on Overall Survival55
Lymph Node Metastasis Spread Patterns and the Effectiveness of Prophylactic Neck Irradiation in Sinonasal Squamous Cell Carcinoma (SNSCC)54
Assessment of Nutritional and Imaging Biomarkers to Predict PEG Tube Placement in Non-HPV-Associated Head and Neck Patients Undergoing Concurrent Chemoradiotherapy54
Predictors of Interstitial Brachytherapy Utilization in Locally Advanced Cervical Cancer and Impact on Overall Survival53
Overall Survival after Y-90 Selective Internal Radiotherapy of Liver Metastases in Oligometastatic Patients53
Systematic Implementation of Effective Quality Assurance Processes for the Assessment of Radiation Target Volumes in Head and Neck Cancer52
Novel Bioprinted Pancreatic Tumor Model: A Translational Tool for Radiotherapy, Chemotherapy and Immunotherapy Efficacy Studies52
Postoperative Radiotherapy can Improve the Disease-Free Survival of EGFR Wild Type Patients with pN2 NSCLC after Complete Resection and Adjuvant Chemotherapy51
Clinical Outcomes in High Risk WHO Grade II Glioma Patients Treated with Upfront TMZ-Based Chemoradiotherapy51
Issue Highlights page50
Effectiveness of Adjuvant Radiotherapy for High Recurrence Risk Patients with Upper Tract Urothelial Carcinoma50
Withdrawn50
NAUTIKA1: A Multicenter Phase II Study with a PD-L1+ Cohort of Patients Receiving Atezolizumab (Atezo) with Low-Dose Stereotactic Body Radiation Therapy (SBRT) as Neoadjuvant Therapy for Resectable St49
The Maximum Standardized Uptake Value in Patients with Recurrent or Persistent Prostate Cancer after Radical Prostatectomy and PSMA-PET-Guided Salvage Radiotherapy – A Multicenter Retrospective Analys49
The Use of Breast Cup Immobilization in Radiation Therapy and Patient Reported Outcomes on Cosmesis and Pain48
Comparison of Diagnostic PET and 4D CT-Based Tumor Delineation for Oligometastatic Lung Tumors48
Single Fraction HDR Brachytherapy for Prostate Cancer: SiFEPI Phase II Trial Results48
Improving Interpretability of Machine Learning in Head and Neck Radiation Therapy Pretreatment Physics Plan Reviews47
Outcomes Associated with the Use of Tissue Equivalent Bolus Tailored by Skin Involvement Status in Postmastectomy Radiotherapy: A Single-Blinded Randomized Clinical Trial47
Withdrawn47
The Utility of Mean Apparent Diffusion Coefficient Value in Patients with Prostate Cancer Treated with Definitive Radiotherapy46
0.49333691596985